Investment analysts at Barclays have increased their price objective for Eli Lilly and Company (LLY) from $420.00 to $500.00, indicating a potential upside of 10. (kidsrkids.com) 43% from the company’s previous close. Several other research firms have also provided positive commentary on LLY, with price targets ranging from $475.00 to $507.00. Analysts have expressed confidence in the LLY stock, resulting in an average rating of “Strong Buy” and a consensus price target of $427.41.
Eli Lilly and Company’s Stock Trading Down 1.3%
The company’s 52-week low and high are $296.32 and $465.26, respectively. With a market capitalization of $429.79 billion, LLY has a quick ratio of 1.02, a current ratio of 1.30, and a debt-to-equity ratio of 1.67. The stock’s price-to-earnings ratio stands at 71.98, with a PEG ratio of 2.10 and a beta of 0.36.
Tuesday’s Trading Performance Eli Lilly and Company (LLY) began trading on Tuesday at $452.76. The stock’s recent performance is in line with its 50-day moving average price of $427.19 and its 200-day moving average price of $374.45.
52-Week Range and Market Capitalization LLY has witnessed a 52-week low of $296.32 and a 52-week high of $465.26. The company currently boasts a market capitalization of $429.79 billion.
Financial Metrics and Ratios Eli Lilly and Company has a quick ratio of 1.02, indicating its ability to meet short-term obligations. The current ratio stands at 1.30, highlighting the company’s ability to cover both short-term and long-term liabilities. With a debt-to-equity ratio of 1.67, LLY relies more on debt financing. The stock’s price-to-earnings ratio is 71.98, with a PEG ratio of 2.10, suggesting its potential for growth. Additionally, the stock has a beta of 0.36, indicating a lower level of volatility compared to the overall market.
Eli Lilly and Company’s Quarterly Earnings Results Fall Short of Expectations
Eli Lilly and Company (LLY) reported quarterly earnings results on Thursday, April 27th. Despite the earnings miss, Eli Lilly and Company maintained a net margin of 20.54% and a return on equity of 61.42%. The firm’s quarterly revenue amounted to $6.96 billion, slightly surpassing analysts’ expectations of $6.87 billion. However, the company’s quarterly revenue declined by 10.9% compared to the same quarter last year. Analysts forecast that Eli Lilly and Company will post 8.78 earnings per share for the current fiscal year.
Quarterly Earnings Fall Short of Estimates Eli Lilly and Company (LLY) released its quarterly earnings results on Thursday, April 27th. The company reported earnings per share (EPS) of $1.62, failing to meet analysts’ consensus estimates of $1.73 by ($0.11).
Strong Financial Metrics Despite missing earnings estimates, Eli Lilly and Company maintained a net margin of 20.54% and a return on equity of 61.42%. These figures indicate the company’s ability to generate profit and effectively utilize shareholders’ investments.
Revenue and Analyst Expectations LLY generated quarterly revenue of $6.96 billion, slightly exceeding analysts’ expectations of $6.87 billion. However, the company experienced a 10.9% decline in revenue compared to the same quarter last year. Analysts predict that Eli Lilly and Company will achieve 8.78 earnings per share for the current fiscal year.
